Kalos Therapeutics Inc

12:45 PM - 1:00 PM, Tuesday, June 4, 2019 ・ SuS - Hall E, Booth 3971, Level 200
Therapeutics company developing drug compounds that utilize natural, native mechanisms to inhibit the growth of cancer cells for the use in cancer and retinal disease treatments. This therapy is designed to improve upon current cancer treatments, such as chemotherapy, which produces undesirable side effects, and to address growing cancer markets around the globe with the possibility of expanding to animal health markets as well.
CEO Co-founder
Kalos Therapeutics Inc